In re Sansone: Federal Circuit Denies Patentability Petition in 99 Days
Petitioner Sansone sought Federal Circuit review of a patentability determination concerning US Application 17/490525, directed to a conformable thermal therapeutic dressing with medical intervention and/or sensing capabilities. The court denied the petition and granted in forma pauperis status, ending the proceeding in 99 days.
Federal Circuit Dismisses Sansone Patentability Petition
This Federal Circuit proceeding, filed January 7, 2026 and captioned In re Sansone, arose from a patentability challenge concerning US Patent Application No. 17/490525. The application is directed to a conformable thermal therapeutic dressing with medical intervention and/or sensing capabilities — a medtech device technology. The case was assigned to the Court of Appeals for the Federal Circuit, the exclusive appellate venue for patent-related matters in the United States.
The recorded basis of termination is 'Petition Dismissed.' The docket order states: 'The petition is denied. The motion to proceed in forma pauperis is granted.' The petition was accordingly dismissed and the in forma pauperis motion resolved in the petitioner's favour, waiving applicable fees. The specific substantive grounds on which the petition was denied are not disclosed in the available record.
The proceeding concluded in 99 days — a notably short window consistent with a threshold denial rather than full merits briefing. Whether the underlying patent application remains pending before the USPTO or was the subject of a prior Board decision is not determinable from the available record. The specific terms and reasoning of the denial are not disclosed.
See Complete Case & Patent Analysis →Filing to Petition Dismissed in 99 days
99 days — Federal Circuit petition resolved well within typical appellate timelines
US17/490525 — Conformable Thermal Therapeutic Dressing
Any company developing conformable dressings, wearable wound care devices, or thermally active therapeutic patches with embedded sensors or intervention delivery should assess exposure to US17/490525. Because the application's current prosecution status is not resolved by this Federal Circuit proceeding, the claims may still be pending, amended, or abandoned — each scenario carries different FTO implications. R&D and product teams should not assume clearance based solely on this petition denial.
Official order — verbatim text
The Federal Circuit's order denies the petition and grants in forma pauperis status in a single two-clause disposition, consistent with a threshold procedural termination. No substantive reasoning on the patentability of US17/490525 is set out in the available record, and the order creates no binding precedent on the merits of the underlying application.
Petition dismissed: what the Federal Circuit's denial means
What a petition denial at the Federal Circuit means
A petition denial at the Federal Circuit indicates the court declined to exercise jurisdiction or found the petition did not meet the threshold requirements for review. It is a procedural termination: no merits ruling was issued on the patentability of the underlying application. The public record does not disclose the specific grounds for denial.
No merits adjudicationSansone's petition closed without appellate relief
The denial means Sansone did not obtain Federal Circuit review of the patentability determination below. The in forma pauperis motion was granted, confirming fee waiver. Whether further avenues — such as a petition for certiorari or renewed prosecution before the USPTO — remain available is not addressed in the available record.
Petition denied; IFP grantedUnderlying application: status not resolved by this order
The Federal Circuit's denial of the petition does not itself cancel or grant US17/490525. The disposition of the underlying application before the USPTO — whether abandoned, pending, or otherwise resolved — is not determinable from the available case record. Practitioners monitoring this technology area should track the application's prosecution history directly.
Application status unresolvedThermal therapeutic dressing IP: no new rights created by this ruling
Because the petition was dismissed without a merits ruling, this proceeding does not establish precedent on the patentability of conformable thermal therapeutic dressings with sensing or intervention capabilities. Companies active in medtech wearables and thermal wound care should monitor prosecution of US17/490525 independently and assess their freedom-to-operate based on the application's current USPTO status.
No precedential effectFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | In re: Sansone | Individual | /Search in Eureka ↗ |
| Defendant | Defendant | Individual | /Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
R&D signals: conformable therapeutic dressing IP landscape
Forward-looking patent and innovation intelligence in the smart wound care and wearable thermal therapy space, surfaced from the Sansone Federal Circuit proceeding.
Sansone's broader filing activity in therapeutic dressing technology
US17/490525 may be one of multiple applications filed by Sansone in the conformable dressing and wearable medtech space. Individual inventors with active prosecution histories sometimes file continuation or divisional applications covering adjacent claim sets. Tracking the full prosecution portfolio associated with this inventive entity can reveal pending claims that may mature into enforceable patents.
Individual inventor portfolioFiling trends in smart wound care and sensing-enabled dressings
The integration of thermal therapy with medical sensing and intervention in flexible, conformable form factors is an active R&D frontier. Filing activity from medtech majors and startups in this space has grown alongside advances in flexible electronics and remote patient monitoring. Mapping recent patent filings can reveal which assignees are building dominant positions in thermally active, sensor-integrated dressing technology.
Smart wound care filing trendsMedtech incumbents' IP in thermal and sensing wound care
Established medtech and wound care companies — including those active in smart dressings and wearable therapeutic devices — hold substantial patent portfolios in adjacent claim space. Understanding how US17/490525's claims map against incumbent filings from companies such as 3M, Smith+Nephew, or Mölnlycke can inform both FTO assessments and competitive intelligence for R&D teams.
Incumbent portfolio mappingAdjacent claim opportunities in thermal-sensing dressing architecture
If the claims of US17/490525 are narrowed or abandoned, gaps may emerge around specific architectural combinations of thermal delivery, embedded sensing, and conformable substrate design. R&D teams developing next-generation wound care or wearable therapeutic platforms should run a white-space analysis to identify protectable differentiation in sensing modality, materials, or intervention delivery mechanism.
Claim white space opportunitySimilar Federal Circuit patentability petition cases in medtech
Explore Federal Circuit petition denials and patentability appeals involving medical device and wearable therapeutic technologies comparable to US17/490525.
What this case signals for medtech patent prosecution IP strategy
The Sansone petition denial highlights threshold barriers at the Federal Circuit and the importance of robust USPTO prosecution strategy for medical device applicants.
Threshold petition standards at the Federal Circuit are high
Pro se and individual applicants seeking Federal Circuit review of patentability determinations face significant procedural hurdles. A denial at the petition stage — resolved in 99 days — suggests the court found the request did not meet jurisdictional or procedural thresholds. Applicants in this position should ensure exhaustion of USPTO appeal options before seeking Federal Circuit review.
Conformable therapeutic dressing technology remains an active IP frontier
The technology described in US17/490525 — conformable thermal dressings with integrated medical intervention and sensing — sits at the intersection of wearable medtech and wound care. Regardless of this proceeding's outcome, the domain attracts significant patent filing activity. Competitors and R&D teams should monitor filing trends in smart wound care and thermal therapeutic devices.
Sansone v Defendant — key questions answered
The Federal Circuit denied the petition in Case No. 26-124, captioned In re Sansone. The recorded basis of termination is 'Petition Dismissed.' The court also granted the motion to proceed in forma pauperis. No merits ruling on the patentability of US17/490525 was issued.
The patent at issue is US Patent Application No. 17/490525, published as US20220125627A1. It is directed to a conformable thermal therapeutic dressing with medical intervention and/or sensing capabilities. The verdict cause is recorded as Patentability/Invalidity-Cancellation Action.
The petition denial does not itself grant, cancel, or abandon US17/490525. It terminates the Federal Circuit proceeding on procedural grounds without a merits ruling. The current status of the underlying application before the USPTO is not determinable from the available case record and should be checked directly in USPTO PAIR or Patent Center.
In forma pauperis (IFP) is a procedural status that allows a party with limited financial means to proceed without paying court filing fees. In In re Sansone, the Federal Circuit granted the IFP motion alongside the petition denial. The grant of IFP does not affect the substantive outcome of the case.
The available record does not indicate that the order was designated as precedential. The two-clause disposition — denying the petition and granting IFP — is consistent with a non-precedential threshold ruling. The order does not address the merits of patentability for conformable thermal therapeutic dressings and does not create binding authority on that question.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.